205 results on '"Tichy, Boris"'
Search Results
2. Cell Tree Rings: the structure of somatic evolution as a human aging timer
3. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression
4. EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells
5. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model
6. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing
7. Single-cell RNA sequencing analysis of T helper cell differentiation and heterogeneity
8. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
9. ERIC recommendations for TP53mutation analysis in chronic lymphocytic leukemia—2024 update
10. Cell Tree Rings: the shape of somatic evolution as a human aging timer
11. Enabling the Implementation of Next-Generation Sequencing into Clinical Diagnosis: Nemhesys Project
12. The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
13. MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus
14. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods
15. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
16. Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model
17. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2
18. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
19. High Expression of Lymphocyte-Activation Gene 3 ( LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated Immunoglobulin Variable Heavy Chain Region ( IGHV) Gene and Reduced Treatment-Free Survival
20. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
21. Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
22. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
23. Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases
24. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer
25. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
26. Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1
27. Effect of procathepsin D activation peptide on gene expression of breast cancer cells
28. Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
29. Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery
30. Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation
31. Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs
32. Transcription Factor YY1 Can Control AID-mediated Mutagenesis
33. Low-burden TP53mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
34. STAT3and TP53mutations associate with poor prognosis in anaplastic large cell lymphoma
35. Transcription factor YY1 can control AID‐mediated mutagenesis in mice
36. Low-Burden TP53 Mutations Occur in Chronic Phase of Myeloproliferative Neoplasms Regardless of Hydroxyurea Administration, Disease Type, and JAK2 Status
37. COBLL1,LPLandZAP70expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates withIGHVmutational status
38. Single Cell Analysis of IG Genes in CLL: Cases with Multiple IGH Rearrangements Are Constituted of Several Independent Clones Even When Indistinguishable By Flow Cytometry
39. Significance of immunoglobulin B-cell receptor features in tumor dynamics of chronic lymphocytic leukemia
40. Transcription factor YY1 can control AID‐mediated mutagenesis in mice.
41. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia
42. Abstract 3084: MicroRNA involvement in DNA damage response and BCR signaling in malignant B cells
43. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods
44. Micro RNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole mi RNome profiling of human hippocampus.
45. COBLL1 , LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
46. Abstract 5198: Identification of microRNAs involved in DNA damage response in malignant B cells and their biological and clinical relevance
47. Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma
48. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
49. Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients
50. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia:a molecular classification with implications for targeted therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.